(Q63320509)
Statements
A Phase IIa Multicenter Double Blind Study to Evaluate the Efficacy and Safety of Low Doses of Oral NT-KO-003 for the Treatment of Multiple Sclerosis (English)
0 references
June 2011
0 references
January 2014
0 references
99
0 references
18 year
0 references
55 year
0 references